Venrock

Activity from announced rounds

Activity in this selectionOct 25, 2026 · Enterprise software · Jan 1, 2026

Venrock is the venture manager whose own Encoded portfolio identifies investor Bryan Roberts.

Recorded funding activity

Encoded develops neurological gene therapies. Other recorded companies include Gitar’s software-review agents and Adcendo’s targeted cancer medicines. Venrock Healthcare Capital Partners remains a separate manager identity.

Sources
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$69M
2 disclosed · full round size, not this investor’s share

By stage

Series B1
Undisclosed1

By primary sector

Enterprise software1
Logistics1

By country

United States2

Rounds

2 in this selection
Gitar

Builds AI agents for code review and continuous integration workflows

$9MUndisclosed
Role not disclosed
GenLogs

Provides a truck intelligence platform using roadside sensors and AI to secure freight networks

$60MSeries B
Role not disclosed